Ankit Kansagra

15PUBLICATIONS
104CO-AUTHORS
Disease surveillanceHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 16, 2025
Validation of a Composite Real-World Mortality Variable Among Patients With Hematologic Malignancies Treated in the United States.

Sharlene Dong, Ankit Kansagra, Gurbakhash Kaur

|Oct 04, 2023
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.

Hemant S Murthy, Mei-Jie Zhang, Karen Chen

|Jan 09, 2023
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.

Doris K Hansen, Surbhi Sidana, Lauren C Peres

|Jun 07, 2022
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice.

Ajeet Gajra, Abigail Zalenski, Aishwarya Sannareddy

|Sep 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.

Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri

|Sep 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.

Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin

Pageof 3

Frequent Collaborators

7 joint publications

Taiga Nishihori

6 joint publications

Akshay Sharma

6 joint publications

Daniel Weisdorf

6 joint publications

Nelli Bejanyan